Cargando…

Neutropenia: occurrence and management in women with breast cancer receiving chemotherapy

OBJECTIVES: to identify the prevalence, and describe the management of, neutropenia throughout the chemotherapy treatment among women with breast cancer. METHODS: observational study, cycles of chemotherapy. 116 neutropenic events were recorded, and 63.3% of the patients presented neutropenia at som...

Descripción completa

Detalles Bibliográficos
Autores principales:	do Nascimento, Talita Garcia, de Andrade, Marceila, de Oliveira, Rosemeire Aparecida, de Almeida, Ana Maria, Gozzo, Thais de Oliveira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Escola de Enfermagem de Ribeirão Preto / Universidade de São Paulo 2014
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292595/ https://www.ncbi.nlm.nih.gov/pubmed/26107839 http://dx.doi.org/10.1590/0104-1169.3305.2416

Ejemplares similares

Is there agreement between evaluators that used two scoring systems to measure acute radiation dermatitis?
por: Fuzissaki, Marceila de Andrade, et al.
Publicado: (2019)

Integrative review of factors related to the nursing diagnosis nausea during antineoplastic chemotherapy
por: Moysés, Aline Maria Bonini, et al.
Publicado: (2016)

Barriers for the inclusion of sexuality in nursing care for women with gynecological and breast cancer: perspective of professionals
por: Ferreira, Simone Mara de Araújo, et al.
Publicado: (2015)

Bloodstream infection in pediatric patients with febrile neutropenia induced by chemotherapy
por: Lima, Mariana Antunes Faria, et al.
Publicado: (2023)

Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors
por: Pfeil, Alena M, et al.
Publicado: (2014)

Myelophthisis as first manifestation of failure of chemotherapy in breast cancer
por: de Oliveira, Leonardo Rodrigues, et al.
Publicado: (2012)

A prospective, real-world, multinational study of febrile neutropenia (FN) occurrence in oncology patients receiving chemotherapy with intermediate risk of FN: a MASCC Neutropenia, Infection, and Myelosuppression Study Group initiative
por: Leon Rapoport, Bernardo, et al.
Publicado: (2023)

Predictive Factors of Neutropenia in HIV-Infected Patients with Malignancy Receiving Chemotherapy or Radiotherapy
por: Suthepwanon, Apisada, et al.
Publicado: (2022)

Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery
por: Schwenkglenks, Matthias, et al.
Publicado: (2010)

Primary Febrile Neutropenia Prophylaxis for Patients Who Receive FEC-D Chemotherapy for Breast Cancer: A Systematic Review
por: Fernandes, Ricardo, et al.
Publicado: (2017)

COVID-19 Prevention Guidance and the Incidence of Febrile Neutropenia in Patients with Breast Cancer Receiving TAC Chemotherapy with Prophylactic Pegfilgrastim
por: Gwak, Hongki, et al.
Publicado: (2022)

Chemotherapy in Pediatric Oncology Patients and the Occurrence of Oral Mucositis
por: Ribeiro, Isabella LA, et al.
Publicado: (2019)

XM02 is superior to placebo and equivalent to Neupogen™ in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy
por: del Giglio, A, et al.
Publicado: (2008)

Chemotherapy induced neutropenia and febrile neutropenia among breast cancer patients in a tertiary hospital in Nigeria
por: Salako, Omolola, et al.
Publicado: (2021)

Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy
por: Hashiguchi, Yasunori, et al.
Publicado: (2015)

Use of biomarkers in the management of febrile neutropenia episodes in children with cancer()
por: de Oliveira, Benigna Maria
Publicado: (2016)

Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy
por: Kim, Chang Gon, et al.
Publicado: (2016)

Pro-inflammatory cytokine ratios determine the clinical course of febrile neutropenia in children receiving chemotherapy
por: Siegmund, Mira, et al.
Publicado: (2020)

Diet Quality Influences the Occurrence of Food Aversions in Women Undergoing Adjuvant Chemotherapy for Breast Cancer
por: Reitz, Luiza Kuhnen, et al.
Publicado: (2022)

OCCURRENCE OF Blastocystis spp. IN UBERABA, MINAS GERAIS, BRAZIL
por: CABRINE-SANTOS, Marlene, et al.
Publicado: (2015)

Emotional Distress in the Relationship of Caregivers and Institutionalized Babies
por: do Nascimento, Rosemeire Aparecida, et al.
Publicado: (2020)

Incidental occurrence of neutropenia in children hospitalised for COVID-19
por: Folino, Francesco, et al.
Publicado: (2022)

Adjuvant Chemotherapy for Breast Cancer in a Patient with Primary Autoimmune Neutropenia
por: Trus, Michael, et al.
Publicado: (2013)

Appropriateness of granulocyte colony-stimulating factor use in patients receiving chemotherapy by febrile neutropenia risk level
por: Baig, Hassam, et al.
Publicado: (2018)

EMOTIONAL REPERCUSSIONS AND QUALITY OF LIFE IN CHILDREN AND ADOLESCENTS UNDERGOING HEMODIALYSIS OR AFTER KIDNEY TRANSPLANTATION
por: Rotella, Ana Amélia Fayer, et al.
Publicado: (2019)

Women with breast cancer taking chemotherapy: depression symptoms and treatment adherence
por: de Souza, Bianca Fresche, et al.
Publicado: (2014)

Management of chemotherapy-associated febrile neutropenia
por: Cameron, D
Publicado: (2009)

A prospective cohort study to evaluate the incidence of febrile neutropenia in patients receiving pegfilgrastim on-body injector versus other options for prophylaxis of febrile neutropenia: breast cancer subgroup analysis
por: Mahtani, Reshma L., et al.
Publicado: (2022)

Stage and histology of cervical cancer in women under 25 years old
por: Vale, Diama Bhadra, et al.
Publicado: (2019)

Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?
por: Boccia, Ralph, et al.
Publicado: (2022)

Risk of chemotherapy-induced febrile neutropenia in cancer patients receiving pegfilgrastim prophylaxis: does timing of administration matter?
por: Weycker, Derek, et al.
Publicado: (2015)

Incidence of Neutropenia in Veterans Receiving Lung Cancer Chemotherapy: A Comparison of Administrative Coding and Electronic Laboratory Data
por: Knerr, Sarah, et al.
Publicado: (2017)

Preoperative Nutritional Status Contributes to the Development of Neutropenia Event in Patients With Gastric Cancer Receiving CAPEOX Adjuvant Chemotherapy
por: Xiao, Ai Tang, et al.
Publicado: (2020)

Prognostic Value of Chemotherapy-Induced Neutropenia at the First Cycle in Invasive Breast Cancer
por: Ma, Rui-Min, et al.
Publicado: (2016)

Incidence of febrile neutropenia with commonly used chemotherapy regimen in localized breast cancer
por: Palukuri, Nageswara Reddy, et al.
Publicado: (2020)

Impact of a Music Intervention on Quality of Life in Breast Cancer Patients Undergoing Chemotherapy: A Randomized Clinical Trial
por: Lima, Talita Uchoa, et al.
Publicado: (2020)

Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia
por: Hoggatt, Jonathan, et al.
Publicado: (2015)

Properdin Levels in Individuals with Chemotherapy-Induced Neutropenia
por: Tsyrkunou, Artsiom, et al.
Publicado: (2016)

The Impact of Baseline Risk Factors on the Incidence of Febrile Neutropenia in Breast Cancer Patients Receiving Chemotherapy with Pegfilgrastim Prophylaxis: A Real-World Data Analysis
por: Li, Edward, et al.
Publicado: (2021)

Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation.
por: Meis, J F, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_21gkr6r0d21piomnvv9h3oojaq